Sumitomo Chemical India
- Market cap
- ₹ 17,977 Cr.
- P/E
- 30.4x
- P/B
- 5.46x
- 52-week range
- 333.7 – 572.05
- ROE
- 18%
- ROCE
- 23%
- Dividend yield
- 0.4%
- Debt / equity
- 0.02
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE, BSE
About
Sumitomo Chemical India Limited is an India-based company. The Company manufactures, imports, and markets products for crop protection, grain fumigation, rodent control, biopesticide, plant nutrition & plant growth regulators, professional pest control, public health insecticides, household pesticides, and feed additives. The plant nutrition & plant growth regulators product category offers Chitto, ika, Danza Power, Hoshi, and Tabol. The household pesticides product category offers VectoBac 12 AS, Sumilarv 0.5 G, and Kemtrek 20 EC. The biological product category offers EXCEL MADHYAM, SUDOCEL, and TRICHO HR. The Company manufactures and supplies Methionine, which is used as a feed additive. It also produces various technical grade pesticides in its manufacturing units with indigenous research and development (R&D) facilities. Its subsidiary, Valent Biosciences LLC, is engaged in producing a range of naturally occurring pesticides and plant growth regulators.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →Sumitomo Chemical India against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)30.4 against a typical 23.3: pricier than most peers (1st = cheapest).23rd of 33
- Sales growth+0.6% against a typical −4.5% from a year earlier.12th of 31
- Profit growth+20.6% against a typical +15.2% from a year earlier.11th of 25
- Share price, 3 months−33.3% against a typical −15.5%.30th of 32
- Size₹ 17,976.7 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).3rd of 31
Latest announcements
Exchange filings and their impact on the company.
- Weak Q2 with revenue down 2.4% and profit down 11% points to flat to slightly lower earnings over the next year.
Sumitomo Chemical India reported Q2 FY27 consolidated revenue of Rs 907.3 crore, down 2.4% from last year, and net profit of Rs 157.4 crore, down 11.4%. For the first half, revenue was flat at Rs 1,970.7 crore while profit rose 4.5% to Rs 371.9 crore helped by a Rs 26.9 crore insurance claim for the Bhavnagar plant fire. The weak peak-season quarter with higher raw material costs suggests subdued earnings momentum ahead.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA by CRISIL- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil AA | Stable | 29 Apr 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 29 Apr 2026 | Reaffirmed | Crisil AA | — | CRISIL | ₹ 200 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 26 Oct 2026 | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 27 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 26 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 27 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 27 Oct 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 4 Aug 2025 | Financial Results | To consider and approve the Unaudited financial results for the quarter ended 30th June, 2025. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 903 | 540 | 664 | 832 | 971 | 622 | 665 | 1,048 | 914 | 552 | 671 | 1,054 |
| Expenses | 715 | 474 | 526 | 670 | 729 | 521 | 548 | 828 | 697 | 456 | 539 | 819 |
| Operating Profit | 188 | 66 | 139 | 162 | 242 | 101 | 117 | 220 | 217 | 96 | 133 | 235 |
| OPM % | 21% | 12% | 21% | 19% | 25% | 16% | 18% | 21% | 24% | 17% | 20% | 22% |
| Other Income | 25 | 27 | 27 | 26 | 31 | 31 | 31 | 39 | 39 | 22 | 32 | 74 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Depreciation | 16 | 16 | 16 | 14 | 15 | 18 | 16 | 15 | 16 | 16 | 16 | 16 |
| Profit before tax | 196 | 76 | 149 | 173 | 257 | 113 | 132 | 242 | 238 | 100 | 147 | 291 |
| Tax % | 27% | 27% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 25% | 25% | 26% |
| Net Profit | 144 | 55 | 109 | 128 | 191 | 84 | 98 | 180 | 178 | 75 | 111 | 217 |
| EPS in Rs | 2.88 | 1.1 | 2.19 | 2.57 | 3.82 | 1.69 | 1.97 | 3.6 | 3.56 | 1.5 | 2.22 | 4.34 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 16%
- 5 Years
- 4%
- 3 Years
- −3%
- TTM
- −3%
- 10 Years
- 24%
- 5 Years
- 10%
- 3 Years
- 3%
- TTM
- 3%
- 10 Years
- —
- 5 Years
- 6%
- 3 Years
- 10%
- TTM
- —
- 10 Years
- 20%
- 5 Years
- 20%
- 3 Years
- 17%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Sumitomo Chemical India | ₹ 334.65 | ₹ 17,977 Cr. | 30.4x | 5.5x | 18% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Anil Nawal
- Chief Financial Officer
- Deepika Trivedi
- Compliance Officer, Company Secretary
- Chetan Shantilal Shah
- Managing Director, Executive Director
- Suresh Ramachandran
- Deputy Managing Director, Executive Director
- Sushil Champaklal Marfatia
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.